104 related articles for article (PubMed ID: 7772645)
21. Divalproex sodium in the treatment of refractory affective disorders.
Schaff MR; Fawcett J; Zajecka JM
J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
[TBL] [Abstract][Full Text] [Related]
22. Long-term use of valproate in primary psychiatric disorders.
Hayes SG
J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
[TBL] [Abstract][Full Text] [Related]
23. Risperidone in the treatment of psychotic depression.
Goto M; Yoshimura R; Kakihara S; Shinkai K; Yamada Y; Kaji K; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):701-7. PubMed ID: 16580110
[TBL] [Abstract][Full Text] [Related]
24. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
25. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.
Berghöfer A; Kossmann B; Müller-Oerlinghausen B
Acta Psychiatr Scand; 1996 May; 93(5):349-54. PubMed ID: 8792904
[TBL] [Abstract][Full Text] [Related]
26. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
Goldberg JF; Burdick KE; Endick CJ
Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985
[TBL] [Abstract][Full Text] [Related]
27. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor.
Lucca A; Lucini V; Catalano M; Alfano M; Smeraldi E
Neuropsychobiology; 1994; 29(3):108-11. PubMed ID: 8022529
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
[TBL] [Abstract][Full Text] [Related]
30. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
Raja M; Azzoni A
Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456
[TBL] [Abstract][Full Text] [Related]
31. Theoretical basis for response to steroid suppression in major depression.
Rothschild AJ; Schatzberg AF
J Clin Psychopharmacol; 1992 Apr; 12(2):142-4. PubMed ID: 1573041
[No Abstract] [Full Text] [Related]
32. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
Saito J; Nishikawa T
Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
[TBL] [Abstract][Full Text] [Related]
33. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study.
Jacobsen FM
J Clin Psychiatry; 1990 Jul; 51(7):298-302. PubMed ID: 2365668
[TBL] [Abstract][Full Text] [Related]
34. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.
Anand A; Malison R; McDougle CJ; Price LH
Biol Psychiatry; 1995 Mar; 37(5):338-40. PubMed ID: 7748987
[No Abstract] [Full Text] [Related]
35. Knowledge and compliance towards lithium therapy among Chinese psychiatric patients in Hong Kong.
Lee S; Wing YK; Wong KC
Aust N Z J Psychiatry; 1992 Sep; 26(3):444-9. PubMed ID: 1417630
[TBL] [Abstract][Full Text] [Related]
36. Erythrocyte choline concentrations in psychiatric disorders.
Stoll AL; Cohen BM; Hanin I
Biol Psychiatry; 1991 Feb; 29(4):309-21. PubMed ID: 2036475
[TBL] [Abstract][Full Text] [Related]
37. Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression.
Orlikov AB; Prakhye IB; Ryzov IV
Biol Psychiatry; 1994 Jul; 36(2):97-102. PubMed ID: 7948450
[TBL] [Abstract][Full Text] [Related]
38. Treatment of depression with clonazepam.
Kishimoto A; Kamata K; Sugihara T; Ishiguro S; Hazama H; Mizukawa R; Kunimoto N
Acta Psychiatr Scand; 1988 Jan; 77(1):81-6. PubMed ID: 3279721
[TBL] [Abstract][Full Text] [Related]
39. [Action and tolerance of dothiepin hydrochloride (Prothiaden) in depressive states during the evolution of psychotic disorders].
Sechter D; De Sahb R; Boudet A; Leutenegger E
Encephale; 1994; 20(4):445-50. PubMed ID: 7988409
[TBL] [Abstract][Full Text] [Related]
40. Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series.
Perugi G; Toni C; Ruffolo G; Frare F; Akiskal H
Pharmacopsychiatry; 2001 Jul; 34(4):137-41. PubMed ID: 11518474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
